SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREN14A - Non-management preliminary proxy statements:
SEC Accession No. 0000910627-10-000055
Filing Date
2010-03-23
Accepted
2010-03-23 16:10:44
Documents
1
Period of Report
2010-03-22

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT genzpren14a031610.txt PREN14A 100614
  Complete submission text file 0000910627-10-000055.txt   102740
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Subject) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: PREN14A | Act: 34 | File No.: 000-14680 | Film No.: 10699467
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICAHN ASSOCIATES CORP. 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153
Business Address C/O ICAHN ASSOCIATES CORP. 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153 212-702-4300
ICAHN CARL C (Filed by) CIK: 0000921669 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: PREN14A
SIC: 0000